Antiviral cell–mediated immunity is initiated by the dendritic cell (DC) network in lymph nodes (LNs). Plasmacytoid DCs (pDCs) are known to migrate to inflamed LNs and produce interferon (IFN)-α, but their other roles in antiviral T cell immunity are unclear. We report that LN-recruited pDCs are activated to create local immune fields that generate antiviral cytotoxic T lymphocytes (CTLs) in association with LNDCs, in a model of cutaneous herpes simplex virus (HSV) infection. Although pDCs alone failed to induce CTLs, in vivo depletion of pDCs impaired CTL-mediated virus eradication. LNDCs from pDC-depleted mice showed impaired cluster formation with T cells and antigen presentation to prime CTLs. Transferring circulating pDC precursors from wild-type, but not CXCR3-deficient, mice to pDC-depleted mice restored CTL induction by impaired LNDCs. In vitro co-culture experiments revealed that pDCs provided help signals that recovered impaired LNDCs in a CD2- and CD40L-dependent manner. pDC-derived IFN-α further stimulated the recovered LNDCs to induce CTLs. Therefore, the help provided by pDCs for LNDCs in primary immune responses seems to be pivotal to optimally inducing anti-HSV CTLs.
Skip Nav Destination
Article navigation
1 August 2005
Article|
August 01 2005
Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs
Hiroyuki Yoneyama,
Hiroyuki Yoneyama
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Kenjiro Matsuno,
Kenjiro Matsuno
2Department of Anatomy (Macro) and SORST, Dokkyo University School of Medicine, Tochigi 321-0293, Japan
Search for other works by this author on:
Etsuko Toda,
Etsuko Toda
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Tetsu Nishiwaki,
Tetsu Nishiwaki
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Naoki Matsuo,
Naoki Matsuo
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Akiko Nakano,
Akiko Nakano
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Shosaku Narumi,
Shosaku Narumi
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Bao Lu,
Bao Lu
3Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Craig Gerard,
Craig Gerard
3Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Sho Ishikawa,
Sho Ishikawa
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Kouji Matsushima
Kouji Matsushima
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Search for other works by this author on:
Hiroyuki Yoneyama
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Kenjiro Matsuno
2Department of Anatomy (Macro) and SORST, Dokkyo University School of Medicine, Tochigi 321-0293, Japan
Etsuko Toda
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Tetsu Nishiwaki
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Naoki Matsuo
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Akiko Nakano
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Shosaku Narumi
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Bao Lu
3Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115
Craig Gerard
3Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA 02115
Sho Ishikawa
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Kouji Matsushima
1Department of Molecular Preventive Medicine and Solution Oriented Research for Science and Technology (SORST), Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
CORRESPONDENCE Kouji Matsushima: [email protected]
Abbreviations used: Ab, antibody; BrdU, 5′-bromo- 2′-deoxyuridine; CFSE, carboxyfluorescein diacetate succinimidyl ester; HEV, high endothelial venule; mDC, myeloid DC; pDC, plasmacytoid DC; PDCA, pDC antigen; PLN, popliteal LN; rpm, revolutions per minute.
Received:
September 22 2004
Accepted:
June 20 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (3): 425–435.
Article history
Received:
September 22 2004
Accepted:
June 20 2005
Citation
Hiroyuki Yoneyama, Kenjiro Matsuno, Etsuko Toda, Tetsu Nishiwaki, Naoki Matsuo, Akiko Nakano, Shosaku Narumi, Bao Lu, Craig Gerard, Sho Ishikawa, Kouji Matsushima; Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs . J Exp Med 1 August 2005; 202 (3): 425–435. doi: https://doi.org/10.1084/jem.20041961
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement